Join the community - networking, discussion and more. Open to all.
More informationCould you write an interesting article for the RQA community?
More informationBuilding the AI and Digital Regulations Service
Outcomes of the EMA Management Board meeting.
18-21 March 2024
The European Medicines Agency (EMA) reminds applicants and marketing authorisation holders that adjusted fees for all applications, except for pharmacovigilance procedures, will be coming into effect on 1 April 2024.
Guidance Documents open for public consultation.
An at-a-glance summary of news from around the agency:
The monthly newsletter from the Medicines and Healthcare products Regulatory Agency and its independent advisor the Commission on Human Medicines
Thousands of counterfeit or unbranded copies of LifeVac anti-choking devices are being sold across the UK. The public is reminded to check their product carefully against the images in MHRA guidance to identify whether it is a counterfeit.
EMA and VICH Adopted and Draft Guidance.
WHO is pleased to announce the second edition of its Week of Quality training program, focusing on In Vitro Diagnostics (IVDs) in 2024. Week of Quality for In Vitro Diagnostics (IVDs): April 15-18, 2024 Week of Quality for Medicines: May 13-16, 2024 Week of Quality for Vaccines & Biotherapeutics: June 10-13, 2024